EXICURE, INC. Increase (Decrease) in Contract with Customer, Asset
EXICURE, INC. (XCUR) reported Increase (Decrease) in Contract with Customer, Asset of -$24.00 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-11.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInContractWithCustomerAsset · last filed 2021-03-11
- EXICURE, INC. increase (decrease) in contract with customer, asset for the quarter ending 2020-12-31 was -$34.00K, a 197.14% decline year-over-year.
- EXICURE, INC. increase (decrease) in contract with customer, asset for the quarter ending 2020-09-30 was $21.00K.
- EXICURE, INC. increase (decrease) in contract with customer, asset for the quarter ending 2020-06-30 was -$13.00K.
- EXICURE, INC. increase (decrease) in contract with customer, asset for the quarter ending 2020-03-31 was $2.00K.
- EXICURE, INC. increase (decrease) in contract with customer, asset for fiscal 2020 was -$24.00K, a 175.00% decline from fiscal 2019.
- EXICURE, INC. increase (decrease) in contract with customer, asset for fiscal 2019 was $32.00K.
- EXICURE, INC. increase (decrease) in contract with customer, asset for fiscal 2018 was -$10.00K, a 176.92% decline from fiscal 2017.
- EXICURE, INC. increase (decrease) in contract with customer, asset for fiscal 2017 was $13.00K.
| Period end | Increase (Decrease) in Contract with Customer, Asset 3 month | Increase (Decrease) in Contract with Customer, Asset 6 month | Increase (Decrease) in Contract with Customer, Asset 9 month | Increase (Decrease) in Contract with Customer, Asset 12 month |
|---|---|---|---|---|
| 2020-12-31 | -$34.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | -$13.00K derived: sum of 2 quarters · filed 2021-03-11 | -$26.00K derived: sum of 3 quarters · filed 2021-03-11 | -$24.00K 10-K · filed 2021-03-11 |
| 2020-09-30 | $21.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $8.00K derived: sum of 2 quarters · filed 2020-11-12 | $10.00K 10-Q · filed 2020-11-12 | $45.00K derived: sum of 4 quarters · filed 2021-03-11 |
| 2020-06-30 | -$13.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | -$11.00K 10-Q · filed 2020-08-12 | $24.00K derived: sum of 3 quarters · filed 2021-03-11 | $24.00K derived: sum of 4 quarters · filed 2021-03-11 |
| 2020-03-31 | $2.00K 10-Q · filed 2020-05-14 | $37.00K derived: sum of 2 quarters · filed 2021-03-11 | $37.00K derived: sum of 3 quarters · filed 2021-03-11 | $34.00K derived: sum of 4 quarters · filed 2021-03-11 |
| 2019-12-31 | $35.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $35.00K derived: sum of 2 quarters · filed 2021-03-11 | $32.00K derived: sum of 3 quarters · filed 2021-03-11 | $32.00K 10-K · filed 2021-03-11 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | -$3.00K derived: sum of 2 quarters · filed 2020-11-12 | -$3.00K 10-Q · filed 2020-11-12 | -$59.00K derived: sum of 4 quarters · filed 2020-11-12 |
| 2019-06-30 | -$3.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | -$3.00K 10-Q · filed 2020-08-12 | -$59.00K derived: sum of 3 quarters · filed 2020-08-12 | -$24.00K derived: sum of 4 quarters · filed 2020-08-12 |
| 2019-03-31 | $0.00 10-Q · filed 2020-05-14 | -$56.00K derived: sum of 2 quarters · filed 2020-05-14 | -$21.00K derived: sum of 3 quarters · filed 2020-05-14 | -$2.00K derived: sum of 4 quarters · filed 2020-05-14 |
| 2018-12-31 | -$56.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10 | -$21.00K derived: sum of 2 quarters · filed 2020-03-10 | -$2.00K derived: sum of 3 quarters · filed 2020-03-10 | -$10.00K 10-K · filed 2020-03-10 |
| 2018-09-30 | $35.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $54.00K derived: sum of 2 quarters · filed 2019-11-07 | $46.00K 10-Q · filed 2019-11-07 | -$142.00K derived: sum of 4 quarters · filed 2019-11-07 |
| 2018-06-30 | $19.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $11.00K 10-Q · filed 2019-08-08 | -$177.00K derived: sum of 3 quarters · filed 2019-09-23 | |
| 2018-03-31 | -$8.00K 10-Q · filed 2019-05-08 | -$196.00K derived: sum of 2 quarters · filed 2019-09-23 | ||
| 2017-12-31 | -$188.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2019-09-23 | $13.00K 10-K/A · filed 2019-09-23 | ||
| 2017-09-30 | $201.00K 10-Q · filed 2018-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |